Scribe Therapeutics, Inc. (SCTX) research

Scribe Therapeutics, Inc.
ShareXLinkedInReddit
Sector
Healthcare
Industry
Biotechnology
Last price
$33.00
As of

Scribe Therapeutics, Inc. (SCTX): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-02.

As of . Source: SEC EDGAR filings for SCTX. Method and limitations.

SHARE THIS CARD

Share the SCTX intelligence card

A branded snapshot of SCTX: the smart money composite, cross family confluence, and the top current signal, with a link back to this page. Post it, download it, or embed it anywhere.

Kresmion SCTX intelligence card preview
Post to X
LIVE TERMINAL

See SCTX live in the terminal

Track SCTX's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.

Open the live SCTX terminal, free

Active signals for SCTX

FREE, NO ACCOUNT

Every signal on SCTX, as it fires

New filings, 13F moves and cross asset signals on SCTX land in the record first.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.

Recent SEC filings, SCTX

Related tickers

See more SCTX signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to SCTXand get the insider, 13F, options, and confluence read in one view.

Open the live SCTX terminal, free